The pharmaceutical world is seeing a major shift in blood sugar treatment with the arrival of GLP-1 patches. These patches offer a seemingly more user-friendly alternative to injections of GLP-1 receptor agonists, lessening the need for daily needle pokes. The approach delivers the drug directly through the epidermis, arguably enhancing patient … Read More